Last updated on August 2019

Open Label Safety Study in Acute Treatment of Migraine


Brief description of study

The purpose of this study is to evaluate safety and tolerability of BHV3000 (rimegepant).

Clinical Study Identifier: NCT03266588

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.